T 2431/12 (Antibody purification/LONZA BIOLOGICALS) of 11.10.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T243112.20181011
- Date of decision
- 11 October 2018
- Case number
- T 2431/12
- Online on
- 10 October 2019
- Petition for review of
- -
- Application number
- 04715906.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antibody purification by Protein A and ion exchange chromatography
- Applicant name
- Lonza Biologics plc.
- Opponent name
- (01): F.Hoffmann-La Roche AG
(02): Symphogen A/S / Biovitrum AB (opposition withdrawn)
(03): Laboratoire Français du Fractionnement et des Biotechnologies
(04): Wyeth LLC
(05): GE Healthcare Bio-Sciences AB
(06): Hexal Biotech GmbH
(07): Eli Lilly and Company - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 123(2)European Patent Convention Art 123(3)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Main request and auxiliary requests I to III, VII and IX - extended scope of protection (yes)
Auxiliary request IV - clarity (no)
Auxiliary request V - inventive step (no)
Auxiliary requests VI and X - unallowable amendment (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.